# DaVita Inc. (DVA)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $15.07B  
**Price:** $198.54 (+0.18%)

> DaVita Inc. is a healthcare services company specializing in kidney care, with a primary focus on providing dialysis treatments for patients with chronic kidney failure and end-stage renal disease. The company operates a large network of outpatient dialysis centers, where it delivers in-center hemodialysis and related care services to adult patients across the United States and internationally. DaVita Inc. also supports home-based dialysis modalities, offering peritoneal dialysis and home hemodialysis, along with clinical education and support programs to help patients manage treatment outside the clinic setting. In addition, the company operates clinical laboratories that perform routine and specialized tests for dialysis patients and provides management and administrative services to affiliated outpatient centers. Headquartered in Denver, Colorado, DaVita Inc. plays a significant role in the healthcare system by serving a critical, medically complex patient population and working alongside physicians, hospitals, and payers to coordinate kidney care and related services.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $13.64B | — | $2.04B | $747M | — |
| 2024 | $12.82B | — | $2.09B | $936M | — |
| 2023 | $12.14B | — | $1.60B | $692M | — |
| 2022 | $11.61B | — | $1.34B | $560M | — |
| 2021 | $11.62B | — | $1.80B | $978M | — |
| 2020 | $11.55B | — | $1.69B | $774M | — |
| 2019 | $11.39B | — | $1.64B | $811M | — |
| 2018 | $11.40B | — | $1.53B | $159M | — |
| 2017 | $10.88B | — | $1.81B | $664M | — |
| 2016 | $10.71B | — | $2.03B | $880M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $17.48B | $16.32B | -$651M | $676M | — |
| 2024 | $17.29B | $15.19B | $121M | $795M | — |
| 2023 | $16.89B | $14.15B | $1.06B | $380M | — |
| 2022 | $16.93B | $14.70B | $712M | $244M | — |
| 2021 | $17.12B | $14.75B | $756M | $462M | — |
| 2020 | $16.99B | $14.09B | $1.38B | $325M | — |
| 2019 | $17.31B | $13.81B | $2.13B | $1.10B | — |
| 2018 | $19.11B | $14.08B | $3.70B | $323M | — |
| 2017 | $18.97B | $13.08B | $4.69B | $508M | — |
| 2016 | $18.76B | $12.93B | $4.65B | $675M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $1.89B | $576M | $1.31B |
| 2024 | $2.02B | $555M | $1.47B |
| 2023 | $2.06B | $568M | $1.49B |
| 2022 | $1.56B | $603M | $961M |
| 2021 | $1.93B | $641M | $1.29B |
| 2020 | $1.98B | $675M | $1.30B |
| 2019 | $2.07B | $767M | $1.31B |
| 2018 | $1.77B | $987M | $785M |
| 2017 | $1.91B | $905M | $1.01B |
| 2016 | $1.97B | $829M | $1.14B |
| 2015 | $1.56B | $708M | $849M |
| 2014 | $1.46B | $641M | $818M |
| 2013 | $1.77B | $618M | $1.16B |
| 2012 | $1.10B | $550M | $551M |
| 2011 | $1.18B | $400M | $780M |

Source: [CompaniesByCap](https://companiesbycap.com/company/DVA)